Patent · US Active

Aryl benzylamine compounds

US8791100B2 · kind B2 · utility

2Cited by

2References

16Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Daniela Angst · Basel, CH
Birgit Bollbuck · Munich, DE
Philipp Janser · Basel, CH
Jean Quancard · Huningue, FR
Nikolaus Johannes Stiefl · Basel, CH

Key dates

Filing date	Jan 28, 2011
Grant date	Jul 29, 2014
Priority date	—
Expiry date	Mar 10, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to substituted aryl-benzylamine compounds, to processes for their production, to their use as pharmaceuticals and to pharmaceutical compositions comprising them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.